
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Description
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
Investor Profile
Johnson & Johnson Innovation – JJDC has made 99 investments, with 14 in the past 12 months and 29% as lead.
Stage Focus
- Series A (27%)
- Series B (23%)
- Series C (18%)
- Series Unknown (7%)
- Series D (6%)
- Post Ipo Equity (6%)
- Seed (5%)
- Series E (2%)
- Grant (2%)
- Private Equity (1%)
Country Focus
- United States (67%)
- Israel (7%)
- United Kingdom (6%)
- France (5%)
- Switzerland (3%)
- The Netherlands (3%)
- China (2%)
- Belgium (2%)
- Canada (1%)
- Australia (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Therapeutics
- Pharmaceutical
- Health Diagnostics
- Life Science
- Biopharma
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.